Fig. 2
From: Inhalable herbal nanotherapeutics targeting lung carcinoma

(A) FTIR spectra of MYR-CPX-SLNs, lactoferrin and Lf-MYR-CPX-SLNs (Lf-F6); (B) In vitro release of MYR from MYR-CPX-SLNs and Lf-MYR-CPX-SLNs, mean ± S.D., (n = 3); (C) Viability of A549 cells measured by the MTT assay following overnight exposure to various concentrations of MYR-phospholipid CPX, MYR-CPX-SLNs and Lf-MYR-CPX-SLNs at 37 ± 0.5 °C, mean ± S.D., (n = 3).